U.S.–China Pharma: Innovative Strategies and Partnership Models

Morgan Lewis is sponsoring the U.S.-China Pharma conference.

This conference focuses on opportunities in licensing in the China market, including best practices and strategies in leveraging partnerships, alliances, collaborations, outsourcing, and in-licensing to improve productivity and contain costs in R&D projects.  It is targeted to vice presidents, directors and managers of pharmaceutical, biotech and life science companies. 

At the conference, Morgan Lewis associate Wenseng "Wendy" Pan will participate in a panel discussion of "Emerging Licensing Opportunities in China." This discussion will cover:

• Maximizing value of drug candidates starting in the preclinical development stage
• Strategies small to mid-size drug developers should take to best position themselves for out-licensing
• Emerging opportunities for licensing in China/Asia

When:
May 23–24, 2011

Where:
Hub Cira Centre
Philadelphia, PA